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Abstract Recent studies point out the important
role of IGF and insulin-related signaling path-
ways in the control of longevity of laboratory
animals. The Ames dwarf mouse is a murine
model of circulating GH and IGF-1 deficiency
that exhibits dwarf phenotype characteristics and
significantly extends lifespan. It is interesting to
know that Ames dwarf mice do not experience an
age-related decline in cognitive function when
compared to their young counterparts. In this
study, the most recent works on local GH and
IGF-1 expression in the hippocampus of Ames
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Introduction
Aging is a multi-factorial process that adversely
affects the fitness of adult organisms over time,
ultimately leading to death. Although the mech-
anisms underlying age-related degeneration and
death in various species need to be identified, an
evolutionally conserved pathway has begun to
emerge (Kirkwood and Austad 2000). Ample
recent evidence, mostly obtained from short-lived
invertebrate organisms (e.g., Drosophila mela-
nogaster and Caenorhabditis elegans), supports
the evolutionary theory of aging, which subse-
quently has become an important basis for
addressing the question of how we age (Guarente
and Kenyon 2000). Studies in model organisms
have begun to map out important genes and
pathways that seem to regulate the pace of aging
and are remarkably conserved from yeast to mice
(Tatar et al. 2003). Interestingly, most of these
Blongevity genes^ are found to be involved in the
control of identifiable signaling pathways that can
be activated by environmental stimuli and influ-
ence life history traits related to stress resistance,
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signals, especially insulin-like growth factor-1
(IGF-1), is closely associated with changes in
animal lifespan and age-dependent function
(Tatar et al. 2003).
In invertebrates, reduced insulin/IGF signaling
pathway significantly increased adult lifespan
(Tatar et al. 2003; Guarente and Kenyon 2000).
In mice, mutations of transcription factors Prop1
and Pit 1 impede pituitary production of growth
hormone, thyroid-stimulating hormone and pro-
lactin; reduce growth rate and adult body size;
and increase adult lifespan by 40% to 60%
(Bartke 2000; Flurkey et al. 2001). Mice with
mutation of growth hormone receptor (GHR-
KO) have similar extension of lifespan (Zhou
et al. 1997). Expressed throughout life, these
mutations produce many secondary alterations in
endocrine systems, including profound suppres-
sion of circulating IGF-1. Furthermore, mice
heterozygous for the disruption of IGF-1 receptor
IGF1r (IGF1r+/j) also live longer than wild-type
controls (Holzenberger et al. 2003). Interestingly,
caloric restriction is well documented to delay
aging and prolong life in laboratory animals. In
caloric-restricted animals, plasma IGF-1 levels
were reduced (Bartke et al. 2003).
Besides the essential role of regulating somatic
growth and development, insulin-like growth
factor-1 is also important in neuronal function.
During development of the nervous system,
IGF-1 plays a prominent neurotrophic role,
stimulating differentiation and survival of spe-
cific neuronal populations (Wilkins et al. 2001;
Vicario-Abejon et al. 2003). In the adult central
nervous system (CNS), IGF-1 is a neuromodula-
tor and is involved in regulation of synaptic
plasticity (Torres-Aleman 1999). IGF-1 levels
are reduced with age. Restoring IGF-1 levels
was reported to enhance neurogenesis and ame-
liorate the age-related cognitive malfunction in
aged brain (Markowska et al. 1998). Further-
more, in transgenic mice with increased expres-
sion of IGF-1 in the brain, the weight and
volume of the brain are increased substantially
due to increases in neuron number and total
myelin (D’Ercole et al. 2002), whereas transgenic
mice with ectopic brain expression of IGFBP-1,
an inhibitor of IGF action, and mice with ablated
IGF-1 gene expression have brain growth retar-
dation with impaired neuronal somatic and den-
dritic growth (D’Ercole et al. 2002; Cheng et al.
2003). Further, IGF-1 gene deletion in humans is
associated with mental retardation (Woods et al.
1996).
The Ames dwarf mouse is a murine model of
circulating GH and IGF-1 deficiency that exhibits
dwarf phenotype characteristics and significantly
extended lifespan, the result of a homozygous
mutation at the Prop-1 locus on chromosome 11
(Bartke 2005; Brown-Borg et al. 1996). Surpris-
ingly, in addition to extended lifespan and
delayed physical aging, Ames dwarf mice do not
experience an age-related decline in cognitive
function when compared with their young coun-
terparts, as measured in behavioral tests (Kinney
et al. 2001b). The results of our recent work show
that genetically GH deficient Ames dwarf mice
have elevated levels of IGF-1 in the hippocam-
pus, while the level of the corresponding mRNA
is as high as in normal mice (Sun et al. 2005a, b).
Aging and hippocampal neurogenesis
Cognitive functions show many alternative out-
comes during aging (Kirkwood and Austad 2000).
Individual trajectories range from the devastating
effects of Alzheimer’s disease (AD) and multi-
infarct dementia (MID) to very mild changes
detected during middle-age that may become
more pronounced in later life without interfering
with most daily activities. The hippocampal
formation, a temporal lobe brain structure in-
volved in various types of learning and memory,
has been implicated in age-related memory
dysfunction. Its functional integrity is critical for
normal memory function, and it is very vulnera-
ble to the process of aging (Jarrard 1995; Driscoll
and Sutherland 2005). The ability to learn new
tasks decreases with age, particularly in spatial
memory (Driscoll and Sutherland 2005). At the
cellular level, synaptic contacts, synaptic strength
and plasticity are reduced during aging (Barnes
1994). Furthermore, the cognitive impairment is
associated with deterioration of hippocampal
circuitry and plasticity (Smith et al. 2000), sug-
gesting that the age-associated spatial learning
182 AGE (2006) 28:181–189impairment might be explained by deficiencies in
hippocampal spatial information processing.
Studies of the hippocampus reveal a number of
types of structural plasticity, including neuro-
genesis in the dentate gyrus, remodeling of
dendrites and the formation and replacement of
synapses. These changes, along with com-
pensatory neurochemical and neuroendocrine
responses, provide the brain with a considerable
amount of resilience. Within the hippocampus
there are several cellular types, including large
principal pyramidal and nonprincipal cells of the
CA regions (Gage 2000) and small granule
neurons of the dentate gyrus (DG). One of the
most exciting neuroscience discoveries of the past
decade is the birth of new neurons that occur in
discrete regions of the adult mammalian brain,
namely the subgranular zone (SGZ) of the
hippocampal dentate gyrus and in the subven-
tricular zone (SVZ) (Altman and Das 1965, 1966;
Gage 2000). In these regions, regulation of adult
neurogenesis is often demonstrated by systemic
injection of an exogenous synthetic S-phase
marker such as bromo-deoxyuridine (BrdU), the
thymidine analogue, which is taken up by di-
viding cells during the S-phase (Miller and
Nowakowski 1988). This technique has shown
that neural progenitor cells arising from the
subgranular zone migrate into the granule cell
layer (GCL) where they differentiate into new
neurons and integrate into the local network,
receiving afferents and sending out functional
efferents (Cameron et al. 1993), whereas SVZ-
born neurons are destined for the olfactory bulb
(OB) (Seaberg and van Der 2003). The process of
neurogenesis in the adult dentate gyrus can be
divided into three distinct phases. First, neural
precursor cells that reside at the border between
the hilus and the granule cell layer undergo cell
division. Second, newborn cells begin to migrate
into the GCL and extend neuronal processes.
Third, the cells integrate into the GCL and begin
to express the neuronal marker. These newly
born neurons have electrophysiological proper-
ties of mature neurons, conduct action potentials,
and make functional synapses with the adult
granule cell (van Praag et al. 2002). It has also
been suggested that newly generated neurons in
adulthood may have an important physiological
role, because blockade of hippocampal neuro-
genesis is reported to inhibit hippocampus-de-
pendent learning (Shors et al. 2001), and because
reducing the population of new interneurons in
the OB impairs odor discrimination (Gheusi et al.
2000).
Neurogenesis in the dentate gyrus occurs
throughout the lifespan, but decreases with age
in rats, mice, monkeys and humans (Zitnik and
Martin 2002; Cameron and McKay 1999; Gould
et al. 1999). Several studies have suggested that
cognitive decline in aging may be attributable to
decreased dentate gyrus neurogenesis (Shors et
al. 2001; Drapeau et al. 2003). Conversely,
hippocampal neurogenesis was reported to in-
crease in aged mice living in an enriched envi-
ronment (Kempermann et al. 2002). Enhanced
neurogenesis is accompanied by improved learn-
ing, exploratory behavior and locomotor activity
(Kempermann et al. 2002). Therefore, it is
suggested that restoring hippocampal neurogene-
sis may be a strategy for reversing age-related
cerebral dysfunction. In addition, growth factors
stimulate proliferation of neuronal precursors in
the adult brain in vitro and in vivo. For example,
fibroblast growth factor (FGF)-2 is expressed in
adult rodent SVZ and SGZ (Goldman 1998), and
intracerebroventricular (ICV) infusions of FGF-2
upregulate dentate neurogenesis considerably in
the aged brain and also increase neurogenesis in
SVZ and neuronal migration to OB (Kuhn et al.
1997; Jin et al. 2003).
Insulin-like growth factor-1 is another interest-
ing component that stimulates neurogenesis, via a
pattern of regulation across lifespan (Anderson
et al. 2002). IGF-1 is a 7.5 kDa protein, and yet it
can be taken up into CSF by a process that is
independent of IGF receptors or binding proteins
(Pulford and Ishii 2001). In rodents, voluntary
exercise in a running wheel has been reported to
increase neurogenesis in the dentate gyrus (van
Praag et al. 2002). Such exercise increases the
uptake of IGF-1 from the blood and activates
c-fos protein expression in dentate gyrus and
other brain regions in a manner that is mim-
icked by IGF-1 administration into the circulation
(Carro et al. 2000). Moreover, immunoneutraliza-
tion of IGF-1 blocks the effects of exercise to
enhance neurogenesis (Trejo et al. 2001). Block-
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exercise-induced neurogenesis, demonstrating
IGF-1 as a necessary component of physical
activity-induced neurogenesis (Trejo et al. 2001).
IGF-1 expression and actions in the central
nervous system
In the murine brain IGF-1 expression begins at
approximately embryonic day 14, peaks in the
second postnatal week, and then declines but
continues throughout life (D’Ercole et al. 1996).
IGF-1 mRNA expression is predominately locat-
ed in neurons and astrocytes and, to a lesser
extent, in oligodendrocytes and their precursors
(Shinar and McMorris 1995). Because IGF-1
mRNA is detected in the subventricular zone
during early development (Bartlett et al. 1992),
IGF-1 may also be expressed by neural stem cells
and early glial progenitors. As CNS development
progresses, regional IGF-1 expression often
peaks concurrently with the proliferation of
neural cells. In addition, this expression occurs
immediately prior to the peak time of myelin-
specific protein gene expression and rapid myeli-
nation (Sorg et al. 1987; Campagnoni and
Macklin 1988). The type-1 IGF receptor, which
is the predominant, if not exclusive, mediator of
IGF-1 actions, is expressed by neuronal stem cells
(Brooker et al. 2000) and subsequently appears to
be expressed in all neural cells. These studies
strongly indicate that IGF-1 plays an important
role in CNS development by acting in an auto-
crine and/or paracrine fashion. In addition, a
variety of insults that result in CNS demyelin-
ation induce IGF-1 gene expression near or at the
sites of injury (Gehrmann et al. 1994; Yao et al.
1995), suggesting a role for IGF-1 in protecting
oligodendrocytes from injury and/or in promoting
their regeneration following injury.
The brain requires enormous supplies of fuel
to support neuroglial growth and process forma-
tion during early postnatal development. Murine
and human brains consume over half the energy
available to the organism as a whole during this
critical period (Gibbons 1998), while undernutri-
tion may result in permanent intellectual deficit
(Chase and Martin 1970). How the developing
brain competes so successfully with peripheral
tissues for resources is unknown. Insulin prefer-
entially enhances fuel and substrate utilization by
peripheral tissues but does not seem to be
involved in the regulation of brain metabolism
(Baskin et al. 1987). Very little insulin is synthe-
sized within the brain (Baskin et al. 1987) and
little circulating insulin can cross the blood–brain
barrier (Reinhardt and Bondy 1994). However,
IGF-1 is abundant in the developing brain, where
it is concentrated in large projection neurons
(Bondy 1991). IGF-1 and insulin receptors are
also homologous, with nearly identical signal-
transducing domains engaging many of the same
intracellular pathways. Recent studies suggest
that endogenous brain IGF-1 may play an essen-
tial, insulin-like role in brain glucose metabolism
(Cheng et al. 2000).
In vitro studies have shown that IGF-1 stim-
ulates the proliferation of neuron progenitors,
induces the differentiation of oligodendrocytes,
and increases the survival of neurons and oligo-
dendrocytes (see review in D’Ercole et al. 2002).
IGF-1 effects on CNS suggested by in vitro
studies have been confirmed in vivo. Multiple
lines of mice with genomic alterations in their
IGF systems have been generated. IGF-1 over-
expressing mice were among the first transgenic
mice generated (Mathews et al. 1988). Depending
upon the tissues and magnitude of transgene
expression among the transgenic mice, postnatal
somatic overgrowth begins at 3–4 weeks of age
and leads to a moderate increase in weight by
early adulthood. The IGF-1 transgenic mice
exhibit disproportional overgrowth of some
organs, most remarkably of the brain (D’Ercole
et al. 2002). Interestingly, transgenic mice with
larger brain weights usually do not exhibit
somatic overgrowth; rather they have modestly
reduced adult body weight and similarly reduced
serum IGF-1 levels (Ye et al. 1995).
Recently, by the use of a variety of promoters
aimed at generating organ- or tissue-specific IGF-
1 overexpression, a number of other IGF-1
transgenic mice have been created (D’Ercole
et al. 2002). At the same time, generation and
study of mice with IGF-1 and the IGF-1 receptor
null mutation are providing direct evidence of
the central role of IGF-1 in somatic growth
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and IGF-R gene exhibit marked in utero and
postnatal growth retardation and have reduced
survival past birth (Liu et al. 1993; Baker et al.
1993; Powell-Braxton et al. 1993). The brains of
IGF-1 knockout (KO) and IGF-1R KO mice are
smaller than those of controls, although the
brains are not as growth-retarded as the body
weights, and the brain phenotype in each appears
to be similar. IGFBP-1 is an inhibitor of IGF
action and would be expected to inhibit the
actions of endogenous IGF-1 and IGF-1I. Using
different promoters, several groups have created
IGFBP-1 transgenic mice. These transgenic mice
exhibit somatic and brain growth retardation
(D’Ercole et al. 1994; Dai et al. 1994). Collec-
tively, these studies provided compelling evi-
dence that IGF-1 promotes growth of the brain
by increasing neuron number, process outgrowth
and synaptogenesis. IGF-1 acts to increase neu-
ron number by increasing the rate of neuron
proliferation while inhibiting apoptosis in place of
naturally occurring neuron death, suggesting its
neuronal protective action. Some regions of the
brain, notably the hippocampus dentate gyrus,
appear to have a greater dependency on the
growth-promoting effect of IGF-1.
Levels of IGF-1 and the type-1 IGF receptor
decrease in several regions of the brain during
normal aging (Sonntag et al. 1995), and adminis-
tration of IGF-1 can counteract some age-related
changes in brain energy metabolism and function
(Lynch et al. 2001). Recent evidence that IGF-1
signaling is involved in the development of
Alzheimer’s diseases (ADs) are gaining attention
(Carro and Torres-Aleman 2004; Carro et al.
2005). High brain amyloid-beta levels are found
at an early age in mutant mice with low circulat-
ing IGF-1, and amyloid-beta burden can be
reduced in aging rats by increasing serum IGF-1
(Carro and Torres-Aleman 2004). Tau phosphor-
ylation, which causes the formation of neurofi-
brillary tangles and senile plaques in AD, was
dramatically increased in the brain of IGF1j/j
mice (Cheng et al. 2005). This evidence suggests
that IGF-1 can protect neurons against insults
relevant to the pathogenesis of Alzheimer’s
disease, stroke and other age-related neurological
disorders and can enhance learning and memory.
Adult neurogenesis in the long-lived mutant mice
Ames dwarf mice
The first mammalian mutant found to have an
increased average and maximal lifespan was the
Ames dwarf mouse (Bartke et al. 2001, 2003;
Brown-Borg et al. 1996). Depending on gender
and genetic background, extensions of about 50%
in average lifespan and 40% in maximal lifespan
are observed (Brown-Borg et al. 1996). The
Ames dwarf mouse is of considerable signifi-
cance: clinical evidence suggests that humans
with mutated Prop1 may show increased longev-
ity (Krzisnik et al. 1999; Rosenbloom et al. 1999).
Ames dwarf mice display phenotypes of dwarfism
(they are about one-third normal size), reduced
growth rate, and deficiencies in circulating GH,
prolactin, thyroid-stimulating hormone (TSH)
and IGF-1 (Bartke et al. 2001, 2003; Brown-Borg
et al. 1996). Males exhibit variable fertility, but
females are infertile as a result of a lack of
prolactin (treatment with prolactin restores fer-
tility) (Bartke et al. 2003). Both genders display
delayed reproductive maturity (Bartke et al.
2001; Brown-Borg et al. 1996). A number of
aging-related phenotypes are also delayed, in-
cluding fatal neoplastic disease and declines in
immune function, locomotor activity, learning
and memory (Ikeno et al. 2003; Kinney et al.
2001b).
Caloric restriction treatment of Ames mice
results in a further lifespan extension, indicating
separate (though probably not fully independent)
underlying mechanisms (Bartke et al. 2001). A
mechanistic difference is also suggested by the
observation that CR decelerates aging (the slope
of the mortality curve decreases), whereas the
mutation in Prop1 delays it (the mortality curve
shifts to the right but maintains its shape) (Bartke
et al. 2001). Moreover, effects of Ames dwarfism
a n dC Ro ng e n ee x p r e s s i o np r o f i l e sa n do n
expression of insulin-related genes are not the
same (Masternak et al. 2004).
GHR-KO mice
GHR-KO mice (Laron dwarf mice) lack a growth
hormone receptor (GHR) because of a disrupted
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thus GH resistant (Zhou et al. 1997). These mice
were generated to model the complete GH
deficiency seen in human Laron syndrome. Laron
syndrome, a recessively inherited disease with
GH resistance, is characterized by very short
stature, facial dysmorphism, truncal obesity,
delayed puberty, recurrent hypoglycemia, low
serum IGF-1 concentrations, elevated serum
GH levels, absent, low, or dysfunctional serum
GH-binding protein, and resistance to GH in
patients (Laron 2002). As in human patients,
growth is stunted in GHR-KO mice (adults are
half the size of wild-type adults), and concen-
trations of circulating IGF-1 are very low to
undetectable (Zhou et al. 1997). The lack of
negative feedback of IGF-1 on GH secretion
results in higher concentrations of circulating
GH. Prolactin levels are also elevated. Plasma
insulin and glucose concentrations are lower
than normal in the GHR-KO mice, but insulin
responsiveness is augmented, and reduced insu-
lin release causes lowered glucose tolerance
(Coschigano et al. 2000; Zhou et al. 1997).
Comparing mouse phenotypes
Interestingly, these two types of long-lived mu-
tant mice exhibit delayed age-related cognitive
decline while experiencing significant increase in
both average and maximum life spans (Kinney
et al. 2001a, b; Bartke et al. 2001). There is an
apparent contradiction between the evidence that
those long-lived mutant mice with a circulating
GH/IGF-1 deficiency have normal or improved
cognitive function and the evidence that a
decrease of GH and IGF-1 expression is related
to cognitive malfunction. Interestingly, recent
findings showed that both hippocampal GH and
IGF-1 protein levels were increased and the
corresponding mRNAs were normal in Ames
dwarf as compared with normal mice (Sun et al.
2005a, b).
Given the previous evidence that circulating
IGF-1 is undetectable in Ames dwarf mice, the
IGF-1 immunoreactivity detected by Western
blot in the hippocampus seems unlikely to be
derived from peripheral circulation and transport
across the blood–brain barrier. Thus, IGF-1
might be produced locally in the hippocampus
and might also act directly on the neuronal
progenitor cells in the DG (Sun et al. 2005a).
Increased phosphorylation of Akt and cyclic
AMP responsive element-binding protein
(CREB) were detected in the hippocampus of
aged Ames dwarf mice (Sun et al. 2005a).
Evidence of activation of the anti-apoptosis signal
transduction cascade was also found in the
hippocampus of old dwarf mice (unpublished
data). These data support the hypothesis that
increase in hippocampal GH and IGF-1 pro-
tein expression and subsequent activation of
PI3K/Akt-CREB and activation of anti-apopto-
sis signals might contribute to the maintenance
of cognitive function and is likely to be
responsible for the integrity of neuronal struc-
ture and maintenance of youthful levels of
cognitive function in these long-lived mice
during aging.
Evidence of increased hippocampal neurogen-
esis was found in the young adult Ames dwarf
mice (Sun et al. 2005b). BrdU labeling studies
showed an increase in numbers of newly gener-
ated cells (BrdU positive) and newborn neurons
(neuronal nuclear antigen and BrdU positive) in
the dentate gyrus of dwarfs compared with nor-
mal mice at 3 months of age (Sun et al. 2005b).
Furthermore, there was a dramatic reduction of
BrdU positive cells in the DG areas of both aged
dwarf and normal mice, indicating an age-depen-
dent decline of hippocampal neurogenesis.
In addition, there was no significant differ-
ence in the total number of BrdU-labeled cells
between aged dwarf and normal mice (unpub-
lished data). However, interestingly, the total
number of newly generated neurons (BrdU
and NeuN double positive) in old dwarf mice
was significantly greater than in old normal
mice (unpublished data). Considering the evi-
dence for a significant increase in hippocampal
IGF-1 protein expression and activation of an
anti-apoptosis signal transduction cascade, it is
likely that the increase in the fraction of
newborn neurons in aged dwarf mice was
due, at least in part, to an effect of local
IGF-1 on cell survival.
Taking these data together, we speculate that
aging influences the balance between neurogen-
186 AGE (2006) 28:181–189esis and apoptosis in the mouse hippocampus as
well as the process of the differentiation of the
neuronal progenitors. Locally produced IGF-1
might work primarily as a promoting factor to
increase neurogenesis in the DG area of the
hippocampus in early adulthood; however, it
functions mainly as a survival factor in the central
nervous system to inhibit neuronal death during
aging.
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